Skip Navigation



NDT Advance Access published online on February 28, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl045
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/7/1994    most recent
gfl045v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Castledine, C.
Right arrow Articles by Kingdon, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castledine, C.
Right arrow Articles by Kingdon, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received December 30, 2005
Accepted January 25, 2006

Case Report

Rosiglitazone as a cause for acute interstitial nephritis

Clare Castledine 1 *, David Wright 1, and Edward Kingdon 1

1 Royal Sussex County Hospital, Brighton, Renal Department, Brighton, E. Sussex, UK

* To whom correspondence should be addressed.
Clare Castledine, E-mail: clare.castledine{at}bsuh.nhs.uk



This article has no Abstract. Keywords: interstitial nephritis; rosiglitazone.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.